Sex Differences in Human Immunodeficiency Virus Persistence and Reservoir Size During Aging.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
24 08 2022
Historique:
received: 22 06 2021
pubmed: 7 10 2021
medline: 30 8 2022
entrez: 6 10 2021
Statut: ppublish

Résumé

Sex differences in human immunodeficiency virus (HIV) reservoir dynamics remain underexplored. Longitudinal samples from virally suppressed midlife women (n = 59, median age 45 years) and age-matched men (n = 31) were analyzed retrospectively. At each time point, we measured sex hormones (by means of enzyme-linked immunosorbent assay) and cellular HIV DNA and RNA (by means of digital droplet polymerase chain reaction). Number of inducible HIV RNA+ cells, which provides an upper estimate of the replication-competent reservoir, was quantified longitudinally in a different subset of 14 women, across well-defined reproductive stages. Mixed-effects models included normalized reservoir outcomes and sex, time since antiretroviral therapy (ART) initiation, and the sex-by-time interaction as predictors. At ART initiation, women and men had median (interquartile range [IQR]) CD4+ T-cell counts of 204/μL (83-306/μL) versus 238/μL (120-284/μL), respectively; median ages of 45 (42-48) versus 47 (43-51) years; and median follow-up times of 79.2/μL (60.5-121.1/μL) versus 66.2/μL (43.2-80.6/μL) months. We observed a significant decline of total HIV DNA over time in both men and women (P < .01). However, the rates of change differed significantly between the sexes (P < .01), with women having a significantly slower rate of decline than men, more pronounced with age. By contrast, the levels of inducible HIV RNA increased incrementally over time in women during reproductive aging (P < .01). In contrast to men, in whom the HIV reservoir steadily declines with aging, the HIV reservoir in women is more dynamic. Total HIV DNA (including intact and defective genomes) declines more slowly in women than in men, while the inducible HIV RNA+ reservoir, which is highly enriched in replication-competent virus, increases in women after menopause.

Sections du résumé

BACKGROUND
Sex differences in human immunodeficiency virus (HIV) reservoir dynamics remain underexplored.
METHODS
Longitudinal samples from virally suppressed midlife women (n = 59, median age 45 years) and age-matched men (n = 31) were analyzed retrospectively. At each time point, we measured sex hormones (by means of enzyme-linked immunosorbent assay) and cellular HIV DNA and RNA (by means of digital droplet polymerase chain reaction). Number of inducible HIV RNA+ cells, which provides an upper estimate of the replication-competent reservoir, was quantified longitudinally in a different subset of 14 women, across well-defined reproductive stages. Mixed-effects models included normalized reservoir outcomes and sex, time since antiretroviral therapy (ART) initiation, and the sex-by-time interaction as predictors.
RESULTS
At ART initiation, women and men had median (interquartile range [IQR]) CD4+ T-cell counts of 204/μL (83-306/μL) versus 238/μL (120-284/μL), respectively; median ages of 45 (42-48) versus 47 (43-51) years; and median follow-up times of 79.2/μL (60.5-121.1/μL) versus 66.2/μL (43.2-80.6/μL) months. We observed a significant decline of total HIV DNA over time in both men and women (P < .01). However, the rates of change differed significantly between the sexes (P < .01), with women having a significantly slower rate of decline than men, more pronounced with age. By contrast, the levels of inducible HIV RNA increased incrementally over time in women during reproductive aging (P < .01).
CONCLUSIONS
In contrast to men, in whom the HIV reservoir steadily declines with aging, the HIV reservoir in women is more dynamic. Total HIV DNA (including intact and defective genomes) declines more slowly in women than in men, while the inducible HIV RNA+ reservoir, which is highly enriched in replication-competent virus, increases in women after menopause.

Identifiants

pubmed: 34612493
pii: 6382188
doi: 10.1093/cid/ciab873
pmc: PMC9402699
doi:

Substances chimiques

RNA 63231-63-0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-80

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI069423
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146245
Pays : United States
Organisme : NICHD NIH HHS
ID : R21 HD094646
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI036214
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068636
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH062512
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI154541
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Nat Med. 2016 Sep;22(9):1043-9
pubmed: 27500724
N Engl J Med. 2001 Mar 8;344(10):720-5
pubmed: 11236775
J Clin Microbiol. 1994 Feb;32(2):292-300
pubmed: 8150937
Obstet Gynecol Int. 2013;2013:340309
pubmed: 24454386
J Virus Erad. 2016 Apr 01;2(2):114-6
pubmed: 27482447
Open Forum Infect Dis. 2020 Jul 11;7(8):ofaa289
pubmed: 32793766
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
J Clin Invest. 2021 Feb 1;131(3):
pubmed: 33301425
J Infect Dis. 2014 Jul 15;209 Suppl 3:S86-92
pubmed: 24966195
J Virol. 2021 Mar 24;:
pubmed: 33762408
PLoS One. 2018 Jan 26;13(1):e0191916
pubmed: 29373606
J Virol. 2016 Mar 28;90(8):3944-3952
pubmed: 26842469
AIDS. 2015 Aug 24;29(13):1665-71
pubmed: 26372277
Bio Protoc. 2015 Jun 5;5(11):
pubmed: 27478862
J Womens Health (Larchmt). 2007 Dec;16(10):1402-11
pubmed: 18062755
J Immunol. 2015 Dec 1;195(11):5327-36
pubmed: 26519527
Menopause. 2012 Jul;19(7):820-4
pubmed: 22549170
Antivir Ther. 2013;18 Suppl 2:45-52
pubmed: 23784724
Nat Commun. 2019 Feb 13;10(1):728
pubmed: 30760706
JCI Insight. 2020 Jul 23;5(14):
pubmed: 32544096
Viral Immunol. 2014 May;27(4):140-50
pubmed: 24801776
Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7795-E7804
pubmed: 30061382
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2575-E2584
pubmed: 29483265
J Clin Invest. 2002 Dec;110(11):1643-50
pubmed: 12464669
J Infect Dis. 2013 Sep 1;208(5):830-8
pubmed: 23757341
J Infect Dis. 2019 Mar 15;219(7):1084-1094
pubmed: 30371873
Nat Med. 2009 Aug;15(8):893-900
pubmed: 19543283
Blood. 2013 May 23;121(21):4321-9
pubmed: 23589672
Nat Med. 2003 Jun;9(6):727-8
pubmed: 12754504
Endocr Rev. 2013 Jun;34(3):309-38
pubmed: 23460719
Viruses. 2020 Jan 21;12(2):
pubmed: 31973022
J Antimicrob Chemother. 2014 Mar;69(3):753-6
pubmed: 24187041
J Infect Dis. 2017 Apr 15;215(8):1212-1220
pubmed: 28199648
JCI Insight. 2020 Feb 27;5(4):
pubmed: 32045386
HIV Clin Trials. 2008 Jul-Aug;9(4):269-82
pubmed: 18753121
PLoS One. 2014 Feb 20;9(2):e89299
pubmed: 24586673
AIDS. 2001 Nov 23;15(17):2251-7
pubmed: 11698698
Science. 2014 Jul 11;345(6193):179-83
pubmed: 24968937
PLoS One. 2013;8(4):e55943
pubmed: 23573183
Menopause. 2013 Sep;20(9):983-90
pubmed: 23531684
Nat Immunol. 2019 Dec;20(12):1584-1593
pubmed: 31745336
Nature. 2019 Feb;566(7742):120-125
pubmed: 30700913
EBioMedicine. 2021 Mar;65:103241
pubmed: 33647768
AIDS. 2015 Feb 20;29(4):411-20
pubmed: 25602681
Science. 2014 Aug 1;345(6196):570-3
pubmed: 25011556
Menopause. 2020 Jan;27(1):66-75
pubmed: 31688411
Int J STD AIDS. 2011 Feb;22(2):67-72
pubmed: 21427426
Blood. 2009 Jun 18;113(25):6304-14
pubmed: 19380868
J Int AIDS Soc. 2016 Feb 18;19(1):20706
pubmed: 26900031
J Inflamm Res. 2013 Dec 27;7:1-7
pubmed: 24399882
Virology. 2013 Sep 1;443(2):375-83
pubmed: 23769242
PLoS One. 2013 Apr 17;8(4):e62069
pubmed: 23614015
Womens Health Issues. 2004 Nov-Dec;14(6):220-6
pubmed: 15589772
J Infect Dis. 2015 Nov 1;212(9):1361-5
pubmed: 25877550
PLoS One. 2010 Oct 12;5(10):e13310
pubmed: 20967271
J Virol. 2014 Jul;88(14):7818-27
pubmed: 24789781
Front Immunol. 2016 Jan 06;6:635
pubmed: 26779182
J Immunol. 2014 Dec 1;193(11):5444-52
pubmed: 25339659
Maturitas. 2013 Oct;76(2):172-8
pubmed: 23993758
J Leukoc Biol. 2017 Oct;102(4):977-988
pubmed: 28733462

Auteurs

Sara Gianella (S)

University of California San Diego, La Jolla, California, USA.

Stephen A Rawlings (SA)

University of California San Diego, La Jolla, California, USA.

Curtis Dobrowolski (C)

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory School of Medicine, Atlanta, Georgia, USA.

Masato Nakazawa (M)

University of California San Diego, La Jolla, California, USA.

Antoine Chaillon (A)

University of California San Diego, La Jolla, California, USA.

Matthew Strain (M)

University of California San Diego, La Jolla, California, USA.

Laura Layman (L)

University of California San Diego, La Jolla, California, USA.

Gemma Caballero (G)

University of California San Diego, La Jolla, California, USA.

Eileen Scully (E)

Johns Hopkins University, Baltimore, Maryland, USA.

Brianna Scott (B)

University of California San Diego, La Jolla, California, USA.

Caitleen Pacis (C)

University of California San Diego, La Jolla, California, USA.

Kathleen M Weber (KM)

Hektoen Institute of Medicine/Cook County Health, Chicago, Illinois, USA.

Alan Landay (A)

Rush University Medical Center, Chicago, Illinois, USAand.

Christy Anderson (C)

University of California San Diego, La Jolla, California, USA.

Jonathan Karn (J)

Case Western Reserve University, Cleveland, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH